A rectal cancer organoid platform to study individual responses to chemoradiation

K Ganesh, C Wu, KP O'Rourke, BC Szeglin, Y Zheng… - Nature medicine, 2019 - nature.com
Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …

Colorectal cancer develops inherent radiosensitivity that can be predicted using patient-derived organoids

…, C Wu, S Bodo, S Klingler, CEG Sauvé, BC Szeglin… - Cancer research, 2022 - AACR
Abstract Analysis of inherent tissue radiosensitivity of patient-derived organoids may
provide a readout predictive of neoadjuvant therapy response to radiation in rectal cancer, …

[HTML][HTML] A claudin-based molecular signature identifies high-risk, chemoresistant colorectal cancer patients

…, M Primeaux, K Pravoverov, C Wu, BC Szeglin… - Cells, 2021 - mdpi.com
Identifying molecular characteristics that are associated with aggressive cancer phenotypes
through gene expression profiling can help predict treatment responses and clinical …

Evaluating the Validity of the Clavien–Dindo Classification in Colectomy Studies: A 90-Day Cost of Care Analysis

…, PD Strombom, RL Gennarelli, BC Szeglin… - Diseases of the Colon …, 2021 - journals.lww.com
BACKGROUND: The Clavien–Dindo classification is widely used to report postoperative
morbidity but may underestimate the severity of colectomy complications. OBJECTIVE: The …

A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer

BC Szeglin, C Wu, MR Marco, HS Park… - Cancer …, 2022 - Wiley Online Library
Background Colorectal cancer is the second‐leading cause of cancer‐related mortality in the
United States and a leading cause of cancer‐related mortality worldwide. Loss of SMAD4, …

Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion

…, J Datta, LC Connell, BC Szeglin… - Cancer …, 2019 - Wiley Online Library
Background Resection of colorectal liver metastases (CLM) can cure disease, but many
patients with extensive disease cannot be fully resected and others recur following surgery. …

A rectal cancer model establishes a platform to study individual responses to chemoradiation

K Ganesh, C Wu, KP O'Rourke, M Adileh, BC Szeglin… - bioRxiv, 2019 - biorxiv.org
Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation,
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …

Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy

…, AM Varghese, A Markowitz, C Wu, B Szeglin… - Clinical Cancer …, 2020 - AACR
C, Tumoroid ex vivo sensitivity to FOLFOX demonstrating relative sensitivity to FOLFOX in
pMMR tumoroids and resistance in dMMR tumoroids with calculated IC50 values reported as …

SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance

…, C Wu, X Chen, J Datta, E Sadot, B Szeglin… - Clinical Cancer …, 2019 - AACR
Purpose: SMAD4 has shown promise in identifying patients with colorectal cancer at high
risk of recurrence or death. Experimental Design: A discovery cohort and independent …

Test–retest reliability of freesurfer measurements within and between sites: Effects of visual approval process

Z Iscan, TB Jin, A Kendrick, B Szeglin, H Lu… - Human brain …, 2015 - Wiley Online Library
In the last decade, many studies have used automated processes to analyze magnetic
resonance imaging (MRI) data such as cortical thickness, which is one indicator of neuronal …